Breaking News Instant updates and real-time market news.

VIVE

Viveve

$2.86

0.01 (0.35%)

08:32
07/10/18
07/10
08:32
07/10/18
08:32

Viveve reports preliminary Q2 revenue $5.5M, consensus $4.85M

Viveve Medical reported preliminary financial results for the second quarter ended June 30, 2018. Estimated total product revenue for the three months ended June 30, 2018, is expected to be approximately $5.5M, representing a 79% increase over total product revenue for the quarter ended June 30, 2017.

VIVE Viveve
$2.86

0.01 (0.35%)

04/17/18
STFL
04/17/18
INITIATION
Target $6
STFL
Buy
Viveve initiated with a Buy at Stifel
Stifel analyst Jonathan Block started Viveve with a Buy rating and $6 price target, stating that his work shows that 23% of OB-GYNs are highly to very highly interested in purchasing a vaginal rejuvenation device in the next 12-24 months. Noting that the stock underperformed in 2017, Block said he believes some of the company's growing pains are behind them.
05/11/18
CHLM
05/11/18
DOWNGRADE
CHLM
Hold
Viveve downgraded to Hold from Buy at Craig-Hallum
05/11/18
CHLM
05/11/18
DOWNGRADE
CHLM
Hold
Viveve downgraded to Hold from Buy at Craig-Hallum
As previously reported, Craig-Hallum analyst Matt Hewitt downgraded Viveve to Hold from Buy and lowered his price target on shares to $3 from $10, after the company reported Q1 earnings and revenue that were below consensus, as well as announcing that the CEO is stepping down. Hewitt believes the company's sales force realignment, buy one, get one promotion on treatment tips, and ongoing transition of certain international markets from distributor to direct all have the potential to weigh on revenue growth in future quarters.
06/19/18
MAXM
06/19/18
NO CHANGE
Target $9
MAXM
Buy
Maxim remains a buyer of Viveve shares after data report
Maxim analyst Anthony Vendetti would continue to be a buyer of Viveve shares after the company's report of positive interim 6-month data from its ongoing 12-month SUI feasibility study. He views SUI as another large market for the company and believes the company's multi-pronged approach of pursuing SUI and female sexual function indications can provide a significant competitive edge for the Viveve System. He maintains a Buy rating and $9 price target on Viveve shares.

TODAY'S FREE FLY STORIES

SYF

Synchrony

$29.63

-0.45 (-1.50%)

, PYPL

PayPal

$77.50

-2.61 (-3.26%)

08:57
10/19/18
10/19
08:57
10/19/18
08:57
Hot Stocks
Synchrony sees PayPal deal accritve to EPS, tailwinds going forward »

Comments provided during…

SYF

Synchrony

$29.63

-0.45 (-1.50%)

PYPL

PayPal

$77.50

-2.61 (-3.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 22

    Oct

  • 30

    Oct

  • 30

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

HON

Honeywell

$155.22

-2.73 (-1.73%)

08:55
10/19/18
10/19
08:55
10/19/18
08:55
Hot Stocks
Honeywell raises FY18 segment margin view to 19.5%-19.6%, up 50-60 bps »

Prior view, as of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

CARA

Cara Therapeutics

$19.94

-0.45 (-2.21%)

08:55
10/19/18
10/19
08:55
10/19/18
08:55
Conference/Events
Cara Therapeutics management to meet with Needham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 27

    Nov

MU

Micron

$41.30

-1.06 (-2.50%)

, AAPL

Apple

$215.98

-5.22 (-2.36%)

08:55
10/19/18
10/19
08:55
10/19/18
08:55
Options
Notable open interest changes for October 19th »

Thursday's total…

MU

Micron

$41.30

-1.06 (-2.50%)

AAPL

Apple

$215.98

-5.22 (-2.36%)

PYPL

PayPal

$77.50

-2.61 (-3.26%)

BAC

Bank of America

$28.26

-0.66 (-2.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

08:55
10/19/18
10/19
08:55
10/19/18
08:55
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

VFC

VF Corp.

$87.07

-2.22 (-2.49%)

08:53
10/19/18
10/19
08:53
10/19/18
08:53
Hot Stocks
VF Corp. sees FY19 North Face revenue growth 7%-8% »

Says closely monitoring…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

DDAIF

Daimler AG

$0.00

(0.00%)

08:53
10/19/18
10/19
08:53
10/19/18
08:53
Periodicals
Breaking Periodicals news story on Daimler AG »

Daimler AG sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOMA

Xoma

$13.71

-2.32 (-14.47%)

, NVS

Novartis

$86.24

0.9 (1.05%)

08:52
10/19/18
10/19
08:52
10/19/18
08:52
Recommendations
Xoma, Novartis, Agenus analyst commentary  »

Xoma 'undeservedly…

XOMA

Xoma

$13.71

-2.32 (-14.47%)

NVS

Novartis

$86.24

0.9 (1.05%)

AGEN

Agenus

$1.99

-0.07 (-3.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 07

    Nov

RUBY

Rubius Therapeutics

$17.10

-0.63 (-3.55%)

08:52
10/19/18
10/19
08:52
10/19/18
08:52
Conference/Events
Rubius Therapeutics has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

MU

Micron

$41.30

-1.06 (-2.50%)

, INTC

Intel

$44.98

-0.92 (-2.00%)

08:51
10/19/18
10/19
08:51
10/19/18
08:51
Recommendations
Micron, Intel analyst commentary  »

Micron acquisition a…

MU

Micron

$41.30

-1.06 (-2.50%)

INTC

Intel

$44.98

-0.92 (-2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

08:50
10/19/18
10/19
08:50
10/19/18
08:50
Conference/Events
Jefferies software analyst to hold an analyst/industry conference call »

Software Analyst DiFucci…

TMUS

T-Mobile

$68.81

-0.32 (-0.46%)

, S

Sprint

$6.37

-0.04 (-0.62%)

08:50
10/19/18
10/19
08:50
10/19/18
08:50
Recommendations
T-Mobile, Sprint analyst commentary  »

Wells Fargo raises odds…

TMUS

T-Mobile

$68.81

-0.32 (-0.46%)

S

Sprint

$6.37

-0.04 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 12

    Nov

BXS

BancorpSouth

$29.19

-1.66 (-5.38%)

08:49
10/19/18
10/19
08:49
10/19/18
08:49
Recommendations
BancorpSouth analyst commentary  »

BancorpSouth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HON

Honeywell

$155.22

-2.73 (-1.73%)

08:48
10/19/18
10/19
08:48
10/19/18
08:48
Hot Stocks
Breaking Hot Stocks news story on Honeywell »

Honeywell says sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

GTLS

Chart Industries

$68.16

0.61 (0.90%)

08:48
10/19/18
10/19
08:48
10/19/18
08:48
Recommendations
Chart Industries analyst commentary  »

Chart Industries still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTI

British American Tobacco

$42.40

-0.69 (-1.60%)

, PM

Philip Morris

$87.48

2.86 (3.38%)

08:47
10/19/18
10/19
08:47
10/19/18
08:47
Periodicals
Regulators weigh idea of confining e-cigarette sales to vape shops, CNBC says »

According to a CNBC…

BTI

British American Tobacco

$42.40

-0.69 (-1.60%)

PM

Philip Morris

$87.48

2.86 (3.38%)

MO

Altria Group

$60.94

0.31 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

ACN

Accenture

$156.20

-2.76 (-1.74%)

, HYG

iShares iBoxx $ High Yield Corporate Bond

$84.86

-0.36 (-0.42%)

08:45
10/19/18
10/19
08:45
10/19/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

ACN

Accenture

$156.20

-2.76 (-1.74%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$84.86

-0.36 (-0.42%)

REV

Revlon

$24.35

-2.14 (-8.08%)

PYX

Pyxus

$34.30

-2.88 (-7.75%)

NEPT

Neptune Wellness

$4.32

-0.08 (-1.82%)

RACE

Ferrari

$114.21

-4.64 (-3.90%)

HEAR

Turtle Beach

$21.77

-0.7001 (-3.12%)

EMES

Emerge Energy

$2.96

-0.185 (-5.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 28

    Oct

  • 06

    Nov

  • 06

    Nov

  • 13

    Nov

QIWI

Qiwi

$12.19

-0.02 (-0.16%)

08:45
10/19/18
10/19
08:45
10/19/18
08:45
Recommendations
Qiwi analyst commentary  »

Qiwi likely to resume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HON

Honeywell

$155.22

-2.73 (-1.73%)

08:44
10/19/18
10/19
08:44
10/19/18
08:44
Hot Stocks
Honeywell says has 'significant balance sheet capacity to deploy' »

Says repurchased $600M of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

QIWI

Qiwi

$12.19

-0.02 (-0.16%)

08:42
10/19/18
10/19
08:42
10/19/18
08:42
Hot Stocks
Qiwi announces partnership agreement with AK Bars Bank for Sovest »

Qiwi announced the launch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APPS

Digital Turbine

$1.37

-0.06 (-4.20%)

, VZ

Verizon

$54.65

0.67 (1.24%)

08:42
10/19/18
10/19
08:42
10/19/18
08:42
Recommendations
Digital Turbine, Verizon, Netflix analyst commentary  »

Roth Capital sees Digital…

APPS

Digital Turbine

$1.37

-0.06 (-4.20%)

VZ

Verizon

$54.65

0.67 (1.24%)

NFLX

Netflix

$346.71

-18.24 (-5.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

  • 15

    Nov

DOV

Dover

$83.46

1.18 (1.43%)

08:41
10/19/18
10/19
08:41
10/19/18
08:41
Recommendations
Dover analyst commentary  »

Dover price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:40
10/19/18
10/19
08:40
10/19/18
08:40
General news
U.S. equities are back on the mend »

U.S. equities are back on…

EBIX

Ebix

$62.07

-0.87 (-1.38%)

08:38
10/19/18
10/19
08:38
10/19/18
08:38
Conference/Events
Ebix to participate in a conference call with Maxim »

Maxim holds a conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VAR

Varian Medical

$105.82

-2.83 (-2.60%)

08:37
10/19/18
10/19
08:37
10/19/18
08:37
Initiation
Varian Medical initiated  »

Varian Medical assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.